Just in case some were wondering how much better CLTX is at binding to GBM cells compared to Her2 and IL13ra2... here is a visual (the more yellow, the better it bound to GBM cells), just look at how consistently well CLTX binds to GBM compared to any other target. Left "primary" is a GBM sample from the actual tumor, whereas TS is a cultured GBM sample.
source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500824/
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $50.77K | 12.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2602327 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18629873 | 23 |
View Market Depth
| Last trade - 15.15pm 25/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |